Employing an automated system, 3D heart tissues are fabricated with cardiomyocytes derived from human induced pluripotent stem cells. The ultra- sensitive plate reader, CLARIOstar®, will analyze rapid beat-to-beat changes (up to 50 Hz) in the fluorescence intensities of dyes that indicate physiological states in engineered 3D heart tissue after drug/compound application.
Ayla Annac, Co-founder and CEO of InvivoSciences commented, "We are especially proud and pleased to establish a long-term relationship with the leading developer and internationally-recognized manufacture of microplate readers, BMG LABTECH."
"InvivoSciences has established themselves as a leader in engineered 3D tissues using pluripotent stem cells," said E.J. Dell, Ph.D., International Marketing Director of BMG LABTECH. "We are pleased to partner with them to create a drug discovery platform that is biologically more relevant to researchers."
In recognition of this partnership InvivoSciences will be sponsoring a workshop during Cell Based Assays Summit in Munich Germany, December 2nd – 4th 2013. BMG LABTECH will also have a short presentation at the workshop to discuss the applications of microplate readers in cell and tissue based assays.
Furthermore, both BMG LABTECH and InvivoSciences will be presenting a workshop tutorial at the Society for Laboratory Automation and Screening (SLAS) convention in San Diego, CA, January 20th 2014.